Invus Global Management, LLC - 13 Feb 2026 SCHEDULE 13G Report for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
NMRA
Shares outstanding
166,626,333 shares
Disclosed Ownership
8,997,822 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
19 Feb 2026, 16:37:30 UTC
Date of event
13 Feb 2026
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 5.4% 8,997,822 8,997,822 0 /s/ Raymond Debbane Raymond Debbane